Spectral Medical Inc. (TSE:EDT – Get Free Report)’s stock price crossed below its fifty day moving average during trading on Friday. The stock has a fifty day moving average of C$1.27 and traded as low as C$1.10. Spectral Medical shares last traded at C$1.11, with a volume of 20,896 shares traded.
Spectral Medical Trading Down 2.6%
The company has a market capitalization of C$325.84 million, a PE ratio of -9.25 and a beta of 0.93. The company has a debt-to-equity ratio of 26.03, a quick ratio of 0.45 and a current ratio of 0.61. The business has a fifty day moving average price of C$1.27 and a 200 day moving average price of C$1.34.
Spectral Medical Company Profile
Spectral is a Phase 3 company seeking U.S. FDA approval for its unique product for the treatment of patients with septic shock, Toraymyxin¿ (‘PMX’). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s FDA cleared Endotoxin Activity Assay (EAA¿), the clinically available test for endotoxin in blood. PMX is approved for therapeutic use in Japan and Europe, licensed by Health Canada, and has been used safely and effectively with over 360,000 units sold worldwide to date.
Further Reading
- Five stocks we like better than Spectral Medical
- Home Depot and Lowe’s Hit 52-Week Lows—But Analysts Aren’t Giving Up
- Utilities Are Bouncing Back—These 2 Giants Could Signal the Next Big Sector Rally
- Q3 Earnings Could Blow Past Consensus—Be Ready for What Comes Next
- Why Wall Street Expects Even More From SanDisk After Its 575% Rally
Receive News & Ratings for Spectral Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spectral Medical and related companies with MarketBeat.com's FREE daily email newsletter.
